Lifecore Biomedical Inc. Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased Lifecore Biomedical Inc. (“Lifecore” or the “Company”) (NASDAQ: LFCR) common stock between October 7, 2020 and March 19, 2024 (the “Class Period”)…. Read MoreJoin Investigation
